We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oxford Biodynamics Plc | LSE:OBD | London | Ordinary Share | GB00BD5H8572 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.01 | 0.31% | 3.26 | 3.26 | 3.40 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 3.26 | 3.26 | 3.26 | 80,619 | 10:15:44 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 1.34M | -10.83M | -0.0347 | -0.94 | 10.14M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 11/9/2024 | 12:55 | UK RNS | Oxford BioDynamics PLC Holding(s) in Company |
| 22/8/2024 | 16:59 | UK RNS | Oxford BioDynamics PLC Holding(s) in Company |
| 22/8/2024 | 11:41 | UK RNS | Oxford BioDynamics PLC Holding(s) in Company |
| 25/7/2024 | 07:00 | UK RNS | Oxford BioDynamics PLC OBD pursuing EpiSwitch as companion diagnostics |
| 21/6/2024 | 15:42 | UK RNS | Oxford BioDynamics PLC Grant of Options |
| 18/6/2024 | 16:58 | ALNC |  Oxford BioDynamics revenue up 49% in first half as test sales rise |
| 18/6/2024 | 07:00 | UK RNS | Oxford BioDynamics PLC Half-year Report |
| 06/6/2024 | 07:00 | UK RNS | Oxford BioDynamics PLC OBD's PSE test to be used in NCI trial |
| 04/6/2024 | 10:28 | ALNC | Oxford BioDynamics develops canine cancer test with 89% accuracy |
| 04/6/2024 | 07:00 | UK RNS | Oxford BioDynamics PLC OBD develops multi-cancer diagnostic test for dogs |
1 Year Oxford Biodynamics Chart |
Intraday Oxford Biodynamics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
